News

NEWS
Press-Release
Software
January 24, 2024
InSysBio to present the new Plugin for Sublime Text and Heta compiler Online

InSysBio’s Heta language is now supported by Sublime Text

InSysBio launches the new Plugin for Sublime Text editor to highlight Heta language code. Heta project is InSysBio’s initiative for the development of infrastructure for modeling in pharmacology and systems biology.
LEARN MORE
NEWS
Press-Release
Software
December 7, 2023
InSysBio to release public beta of fIVE Calculator

fIVE Calculator is Shiny application to estimate model parameters

Now InSysBio presents public beta release of fIVE Calculator which is a web application designed to automatically calculate kinetic parameters from in vitro experiments for modeling of biosystems.
LEARN MORE
NEWS
Press-Release
Software
April 6, 2023
InSysBio to release Immune Response Template 3.6.2 for QSP modeling

The usability of search within IRT is enhanced

InSysBio launches Immune Response Template (IRT) version 3.6.2. IRT update focuses on usability and efficiency of search for information on the platform.
LEARN MORE
NEWS
Publication
January 16, 2023
InSysBio team to publish the new article “Receptor occupancy assessment and interpretation in terms of quantitative systems pharmacology: nivolumab case study”
The new article by Dmitry Shchelokov and Oleg Demin Jr was published in mAbs journal at the end of December 2022
LEARN MORE
NEWS
Press-Release
Software
December 14, 2022
InSysBio to release Immune Response Template for QSP modeling in Oncology

IRT Onco version is focused on tumor-specific immune response

InSysBio launches the Oncology version of Immune Response Template (IRT). IRT in Oncology represents a QSP platform of immune system in cancer, simultaneously being a tool for development of QSP and mechanistic models related to tumor-specific immune response.
LEARN MORE
NEWS
Press-Release
November 9, 2022
InSysBio to start the operation of new Headquarters and new branch office
InSysBio announces the start of operation of Headquarters in the United Kingdom. At the same time, the new branch office has been founded in Cyprus and part of InSysBio team has relocated there, thus, expanding the company’s presence.
LEARN MORE
March 2025
MoTuWeThFrSaSu
     
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
1. 19 Mar 2025 15:40 The project aims at mechanistic modeling of antibodies to predict pharmacokinetics and target occupancy in cerebrospinal fluid InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces its collaboration with discoveric bio alpha, a biotechnology company taking next generation antibody technologies into Alzheimer’s Disease
20
21
22
23
24
25
26
1. 26 Mar 2025 00:12 InSysBio to participate in AACR 2025 InSysBio announces its participation in AACR Annual Meeting 2025 which is to be held from April 25-30, 2025, at McCormick Place Convention Center, Chicago, Illinois, USA. InSysBio team is going to present their QSP modeling services and software to optimize drug development at Booth #4845 and 3 posters in frames of the Meeting
27
28
29
30
31
      
Upcoming Events
25.04
InSysBio to participate in AACR 2025
Tags